Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MicroRNAs (miRNAs) are frequently dysregulated in human cancers and can act as potent oncogenes or tumor suppressor genes. Aberrant expression of miR-424 has been identified in some types of cancer, however, its expression and potential biologic role in
endometrial cancer
are remains to be determined. In the present study, we demonstrated that miR-424 was downregulated in human
endometrial cancer
and suppressed growth of the human Ishikawa and HEC-1B
endometrial cancer
cell lines. Bioinformatics analysis indicated that
E2F7
was a putative target of miR-424. In a luciferase reporter system, we confirmed that
E2F7
was a direct target gene of miR-424. Furthermore, knockdown of
E2F7
inhibited Ishikawa and HEC-1B cell growth. These findings indicate that miR-424 targets the
E2F7
transcript and suppresses
endometrial cancer
cell growth, suggesting that miR-424 has a tumor suppressive role in human
endometrial cancer
pathogenesis.
...
PMID:MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. 2570 47
Our previous study explored the roles of microRNA-424 (miR-424) in the development of
endometrial carcinoma
(EC) and analyzed the miR-424/
E2F7
axis in EC cell growth. In this study, we investigated the status of miR-424 in human
endometrial cancer
tissues, which were collected from a cohort of Zunyi patients. We found that the expression level of miR-424 was associated with clinical tumor stage, cell differentiation, lymph node metastasis and cell migration ability. Cell function experiments demonstrated that miR-424 overexpression suppressed the invasion and migration abilities of
endometrial carcinoma
cells
in vitro
. Bioinformatic predictions and dual-luciferase reporter assays suggested E2F6 as a possible target of miR-424. RT-PCR and western blot assays demonstrated that miR-424 transfection reduced the expression level of E2F6, while inhibiting miR-424 with ASO-miR-424 (antisense oligonucleotides of miR-424) increased the expression level of E2F6. Cell function experiments indicated that E2F6 transfection rescued the EC cell phenotype induced by miR-424. In addition, we also found that E2F6 negatively regulated miR-424 expression in EC cells. In summary, our results demonstrated that the miR-424/E2F6 feedback loop modulates cell invasion, migration and EMT in EC and that the miR-424/E2Fs regulation network may serve as a new and potentially important therapeutic target in EC.
...
PMID:MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinoma. 2937 86